SCHEMBL31662926

SCHEMBL31662926

O=Cc1ccccc1-c1ccn[nH]1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.56
SCN4A P35499 2/20 0.47
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
KMT2A Q03164 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
HPGDS O60760 1/20 0.42
XDH P47989 1/20 0.41
PIM1 P11309 1/20 0.39
NPC1 O15118 1/20 0.39
LTA4H P09960 1/20 0.39
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 1/20 0.39
ADRA1A P35348 2/20 0.38
ADRA1B P35368 2/20 0.38
ADRA1D P25100 1/20 0.38
PDPK1 O15530 1/20 0.38
BCAT2 O15382 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31662985 0.76 IDO1 (0.40) IDO1SCN4AHPGDSPIM1NPC1
SCHEMBL13388290 0.75 TRIM24 (0.46) IDO1SCN4AMEN1LMNATHRB
SCHEMBL1501845 0.72 IDO1 (1.00) IDO1SCN4AMEN1KMT2AHPGDS
SCHEMBL29998937 0.72 IDO1 (1.00) IDO1SCN4AMEN1KMT2AHPGDS
SCHEMBL31175932 0.72 KMT2A (0.71) MEN1LMNATHRBBLMKMT2A
SCHEMBL249552 0.72 KMT2A (0.71) MEN1LMNATHRBBLMKMT2A
SCHEMBL23350640 0.71 IDO1 (0.62) IDO1SCN4AMEN1LMNAKMT2A
SCHEMBL2339759 0.71 IDO1 (0.62) IDO1SCN4AHPGDSPIM1NPC1
SCHEMBL21324986 0.71 IDO1 (0.62) IDO1SCN4AMEN1KMT2AHPGDS
SCHEMBL29693625 0.71 IDO1 (0.62) IDO1SCN4AHPGDSPIM1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025149498-A1 BENZYLPIPERIDINE DERIVATIVES AS TRP4 ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES ASTRAZENECA AB (SE) 2025-07-17 WO disclosed